March has ushered in a wave of re-openings across the U.S., and Texas scrapped a requirement to wear masks. Commuting reached its highest level since the pandemic began, and New York City could offer vaccines to all of its residents by late April. But this rush to normality defies warnings that coronavirus variants could spur a fourth American infection wave. Meanwhile Bloomberg Opinion tells of an editor who got both doses of the Pfizer-BioNTech vaccine and still tested positive. Elsewhere, Israel shows the world how difficult life will be for anyone who doesn’t get inoculated. European leaders are losing faith in the EU’s ability to coordinate vaccination, so they’re making back-up arrangements with third parties, which is probably something that should worry the bloc.

Bloomberg is tracking the progress of coronavirus vaccines while mapping the pandemic globally and across America. 

What you’ll want to read this weekend

The latest jobs report added to evidence that the U.S. recovery may be regaining momentum, although the unemployment rate among Blacks bucked the trend and almost 10 million Americans are still jobless. There is some good news though, as it seems the idea of a four-day work week may be a winner, Bloomberg Businessweek reports.

Photographer: Xavier Lalanne-Tauzia for Bloomberg Businessweek

Photographer: Xavier Lalanne-Tauzia for Bloomberg Businessweek

Investors are exiting stocks that have been winners during the pandemic and the SPAC mania is showing signs of froth. Robinhood traders may risk enormous wealth destruction, investment management firm Bernstein warned. And here’s how to file your taxes after spending the year working remotely and day-trading.

In the latest fight for your on-screen attention: Netflix debuts a feature that resembles TikTok, and Nintendo has plans for a new Switch with a bigger screen. USA Network, a fallen king of cable, is betting that live sports will get viewers back.

China’s addiction to online shopping is killing its green packaging drive. Besides joining the shift to electric vehicles, how else can you slow down climate change? The answer, according to Bloomberg Green, is stop  wasting food.

Photographer: SaskiaAcht/iStockphoto/Getty Images

Photographer: SaskiaAcht/iStockphoto/Getty Images

Brazil’s Fasano hotel arrived in New York City, touting so much exclusivity that it can’t even be rented by the night. Take a tour of the the city’s newest cultural landmark. Meanwhile, a historic social club for Manhattan’s power brokers filed for bankruptcy.

What you’ll need to know next week

• Trial begins for four police charged with killing George Floyd.
• The United Nations marks International Women’s Day.
• China’s Premier Li Keqiang caps the National People’s Congress.
• Schools reopen in England, months after Boris Johnson shut them.
• FC Barcelona, home to Leo Messi, elects a new president.

What you’ll want to read in Businessweek

Pfizer’s Fast and Fraught Vaccine Distribution

Pfizer and BioNTech are heroes of the pandemic for their Covid-fighting wonder shots. But Pfizer’s vaccine distribution strategy has angered several countries. To apportion doses, it uses an opaque process that appears to have involved a mix of order size, position in the queue, production forecasts, calls from world leaders, the potential to advance the science, and of course the desire to make a profit.

Like getting Weekend Reading? Subscribe to Bloomberg.com for unlimited access to trusted, data-driven journalism and gain expert analysis from exclusive subscriber-only newsletters.

Leap ahead of the competition: Get the news and ideas shaping global markets every morning with Bloomberg Surveillance. Bloomberg’s Tom Keene, Jon Ferro and Paul Sweeney are your go-to source for the latest on economics, finance, investment, politics and international relations. Subscribe now via Apple Podcasts, Spotify or wherever else you listen.

Download the Bloomberg app: It’s available for iOS and Android.

Before it’s here, it’s on the Bloomberg Terminal. Find out more about how the Terminal delivers information and analysis that financial professionals can’t find anywhere else. Learn more.